Researchers see promise in treatment for autism symptoms

04/26/2012 | Disability Scoop

A drug compound known as GRN-529 is showing promise for the treatment of repetitive behaviors and socialization, considered to be two major facets of autism, researchers say. "Our findings suggest a strategy for developing a single treatment that could target multiple diagnostic symptoms," said the National Institute of Mental Health's Jacqueline Crawley, who worked on the study that was published Wednesday in the journal Science Translational Medicine.

View Full Article in:

Disability Scoop

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Technical Assistance Consultant
American Institutes for Research
Washington, DC
Research Associate (7846)
American Institutes for Research
Washington, DC
Teacher
Saudi Aramco
Dhahran